Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2012
10/02/2012CA2453676C Thermotherapy via targeted delivery of nanoscale magnetic particles
10/02/2012CA2430135C Recombinant anti-cd30 antibodies and uses thereof
10/02/2012CA2412795C Improved liposomal camptothecins and uses thereof
10/02/2012CA2309003C Insect cells or fractions as adjuvant for antigens
10/02/2012CA2223269C Hepatocyte growth factor receptor antagonists and uses thereof
09/2012
09/27/2012WO2012129305A1 Combination therapy
09/27/2012WO2012129232A1 Compositions for the treatment of psychotic or neurological disorders
09/27/2012WO2012129145A1 Nscle combination therapy
09/27/2012WO2012128653A1 Use of anastrozole and vitamin d analogue in the combined therapy of breast cancer
09/27/2012WO2012127885A1 Tetrahydrocarboline derivative
09/27/2012WO2012127871A1 Combination medicine for treatment of depression
09/27/2012WO2012127441A1 Treatment of proliferative disorders with a chemiluminescent agent
09/27/2012WO2012127393A1 COMBINATIONS OF ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATORS AND mGluR5 ANTAGONISTS FOR USE IN DOPAMINE INDUCED DYSKINESIA IN PARKINSON'S DISEASE
09/27/2012WO2012127012A1 Biphenyl tricyclic quinazoline compounds
09/27/2012WO2012126965A1 Drug-free compositions and methods for diminishing peripheral inflammation and pain
09/27/2012WO2012126472A1 Gaba-c receptor agonists or antagonists for use in the treatment of vascular diseases
09/27/2012WO2012106287A3 Methods of treating acute kidney injury with retinoc acid
09/27/2012WO2012069658A4 Immunomodulatory compositions comprising hydralazine for the treatment gastrointestinal disorders
09/27/2012US20120244235 Compositions for alleviating inflammation and oxidative stress in a mammal
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244214 Methods for treating multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione in combination with proteasome inhibitor
09/27/2012US20120244175 Tumor specific animal proteins
09/27/2012CA2830458A1 Combinations of alpha 7 nicotinic acetylcholine receptor activators and mglur5 antagonists for use in dopamine induced dyskinesia in parkinson's disease
09/26/2012EP2502995A1 Pharmaceutical composition
09/26/2012EP2502985A1 Method for inducing differentiation of dental pulp cells into odontoblasts
09/26/2012EP2502635A1 Combined formulations for the treatment of male infertility
09/26/2012EP2501709A2 2'-fluoro-6'-methylene carbocyclic nucleosides and methods of treating viral infections
09/26/2012EP2501700A1 Furopyridinyl-substituted 1,4-dihydropyridine derivatives and methods of use thereof
09/26/2012EP2501410A2 Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
09/26/2012EP2501228A1 Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
09/26/2012EP2501227A1 Treatment of ophthalmic conditions with fluorenone derivatives
09/26/2012EP2056829B9 Using pi3k and mek modulators in treatments of cancer
09/26/2012CN1798576B Drug for preventing or treating angiogenic eye diseases
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1
09/26/2012CN102695954A Method for screening drug efficacious in treating dry eye and/or keratoconjunctival disorders and pharmaceutical composition obtained thereby
09/26/2012CN102695507A Combination therapy for treating cancer and diagnostic assays for use therein
09/26/2012CN102695504A Combination cancer therapy with HSP90 inhibitory compounds
09/26/2012CN102690879A Application of CDK17 gene and expression product thereof
09/26/2012CN102690878A Application of CDK18 gene and expression product thereof
09/26/2012CN102690877A Application of CSNK1A1 gene and expression product thereof
09/26/2012CN102690876A Application of CSNK1G3 gene and expression product thereof
09/26/2012CN102690875A Application of CDK14 gene and expression product thereof
09/26/2012CN102690872A Application of TRIM28 gene and its expression product
09/26/2012CN102690871A Application of TEX14 gene and its expression product
09/26/2012CN102690868A Application of PDK3 gene and its expression product
09/26/2012CN102690867A Application of NLK gene and its expression product
09/26/2012CN102690866A Application of TRPM7 gene and its expression product
09/26/2012CN102690865A MELK gene and application of its expression product
09/26/2012CN102688499A Albumin-polyethylene glycol-medicinal molecular conjugate
09/26/2012CN102688493A Pharmaceutical composition containing resveratrol, resveratrol derivative and Bc1-2 inhibitor, and application thereof
09/26/2012CN102688492A Compositions and methods for anti-inflammatory treatments
09/26/2012CN102688491A MET inhibitors for enhancing radiotherapy efficacy
09/26/2012CN102688490A Pharmaceutical composition containing evodiamine, evodiamine derivative and Bc1-2 inhibitor, and the application
09/26/2012CN102688489A Pharmaceutical composition containing triptolide, triptolide derivative and Bc1-2 inhibitor and application thereof
09/26/2012CN102688223A Anti-cancer drug-loading nanofiber film and preparation method thereof
09/26/2012CN102688200A Plant anti-cancer targeting nano-preparation, and preparation method thereof
09/26/2012CN101711755B Pressure sensitive adhesive matrix device or system for the treatment or prevention of onychomycosis or tinea pedis
09/26/2012CN101389339B Therapeutic agent for diabetes
09/26/2012CN101332303B Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing blood glp-1 level
09/25/2012US8273916 Crystal comprising (2R)-2-propyloctanoic acid and amine
09/25/2012US8273895 NK1 antagonists
09/25/2012US8273794 7-[isopropyl(phenyl)amino]-7-oxoheptanoic acid, 3-(2-Hydroxy-benzoylamino)-butyric acid, 4-Oxo-4-phenyl-butyric acid, 10-(2-Hydroxy-phenyl)-10-oxo-decanoic acid, 4-(4-Methoxy-phenyl)-4-oxo-butyric acid: promoting the absorption of the active agent
09/25/2012US8273713 Dietetics, eating disorders, antidiabetic agents
09/25/2012US8273548 Nucleic acids encoding a human PAP1 polypeptide
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2653929C Screening method for prokinetic agent
09/25/2012CA2567400C Solid pharmaceutical formulation
09/25/2012CA2529984C Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
09/25/2012CA2526338C Use of compositions comprising an estrogenic component for the treatment and prevention of musculoskeletal pain
09/25/2012CA2523188C Methods for treatment of parkinson's disease
09/25/2012CA2491524C Vaccine against salmonid rickettsial septicaemia
09/20/2012WO2012125510A1 Combination therapies for hematologic malignancies
09/20/2012WO2012125486A1 Combination chemotherapy for treating cancer
09/20/2012WO2012125214A1 Topical nitric oxide systems and methods of use thereof
09/20/2012WO2012124649A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/20/2012WO2012124214A1 Intraoral retaining agent for animal use, intraoral environment-improving agent for animal use, and intraoral environment-improving method for animal use
09/20/2012WO2012123774A1 Glycolytic inhibitor with cytotoxic agent for use in the treatment of a cancer
09/20/2012WO2012123613A1 Inhibitors of s1p receptors for the treatment of calcific aortic stenosis
09/20/2012WO2012123504A1 Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence
09/20/2012WO2012103186A3 Androgen composition for treating an opthalmic condition
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120238728 Multivalent antibodies and uses therefor
09/20/2012US20120238624 Formulations for the treatment of pain
09/20/2012US20120238584 5-HT1A receptor subtype agonist
09/20/2012US20120238583 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitors
09/20/2012US20120238500 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
09/20/2012US20120237603 Abuse-resistant opioid dosage form
09/20/2012US20120237595 Methods for treating amyloidosis using 4-(amino)-2-(2,6-dioxo(3-piperidyl))- isoindoline-1,3-dione
09/20/2012US20120237514 Vascular endothelial cell growth factor antagonists and uses thereof
09/20/2012US20120237449 Methods for treating neural cell swelling
09/20/2012DE102011015142A1 Agens zur Prophylaxe und Behandlung altersassoziierter Krankheiten und Störungen sowie zur Verlängerung der Lebensdauer Agent for the prophylaxis and treatment of age-related diseases and disorders, as well as extending the life
09/20/2012CA2830298A1 Topical nitric oxide systems and methods of use thereof
09/20/2012CA2829096A1 Combination therapies for hematologic malignancies
09/20/2012CA2827629A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these
09/19/2012EP2500438A2 Novel compositions and methods for the treatment of psoriasis
09/19/2012EP2500360A2 Compositions and Methods for Diagnosing and Treating Cancer
09/19/2012EP2500038A1 Pharmaceutical composition for external use
09/19/2012EP2500025A1 Oligo-guluronate and galacturonate compositions
09/19/2012EP2500024A1 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
1 ... 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 ... 1151